Our industry is facing challenges that have caused drug development costs and timelines to increase at alarming rates. The number of new drug submissions has dropped by half since 1995, while at the same time, pharmaceutical and biotech companies are spending three times as much money on R&D.

The challenges and delays that occur during drug development present a greater opportunity for sponsors to evaluate better ways to optimize productivity and mitigate risk. Many sponsors have discovered the answer does not lie within their own organization, but rather in the innovation and services of another.

Coram Clinical Trials' “Flexible Subject Flow” is an example of an innovative and unique approach to addressing clinical trial sponsor's concerns and trial delays. By expanding clinical research beyond the investigator site into the home, Coram Clinical Trials can help address challenges associated with subject recruitment, retention, and compliance, while allowing the sponsor to gain real-world drug effectiveness experience.

Expanding Clinical Research Beyond The Investigator Site

Coram Clinical Trials' unique approach to in-home trial visits optimizes subject convenience and helps:

• Shorten recruitment time
• Improve subject retention / decrease drop-out rates
• Improve subject compliance
• Gain real-world drug effectiveness experience